Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Bier Block vs IV in Upper Extremity Surgery
NCT04673877Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2021
- Primary completion
- Aug 2022
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vancomycin in Infection (2 arms), sponsored by Mayo Clinic. Primary endpoint: Tissue concentrations of vancomycin. Started Aug 2021; status: completed.
02
Drugs
vancomycin
03
Conditions
Infection
Beyond the preview
Go deeper on NCT04673877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04673877.